Literature DB >> 9576548

Neuropsychological deficits in multiple sclerosis after acute relapse.

J Foong1, L Rozewicz, G Quaghebeur, A J Thompson, D H Miller, M A Ron.   

Abstract

OBJECTIVES: To examine cognitive and neurological changes and their relation to brain pathology in patients with multiple sclerosis during acute relapse.
METHODS: Thirteen patients with multiple sclerosis were examined with a battery of neuropsychological tests during acute relapse and six weeks later. Their performance was compared with the performance of 10 controls matched for age and premorbid IQ. Gadolinium (Gd) enhanced MRI was also performed in patients on both occasions.
RESULTS: The patients with multiple sclerosis performed significantly worse than controls on most tests of attention and memory during acute relapse and in remission. At follow up there was a significant or trend of improvement in performance on some tests of attention for patients in whom the Gd enhanced lesion load had decreased. In this subgroup of patients, their improvement also correlated significantly with the reduction in acute lesion load.
CONCLUSIONS: The findings suggest that certain neuropsychological deficits detected during an acute relapse may be reversible, particularly in patients who initially have mild cognitive impairment.

Entities:  

Mesh:

Year:  1998        PMID: 9576548      PMCID: PMC2170050          DOI: 10.1136/jnnp.64.4.529

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Stress and exacerbations in multiple sclerosis: whether stress triggers relapses remains a conundrum.

Authors:  Ian Galea; Tracey A Newman; Yori Gidron
Journal:  BMJ       Date:  2004-01-31

Review 2.  Cognitive impairment in early stages of multiple sclerosis.

Authors:  Maria Pia Amato; E Portaccio; B Goretti; V Zipoli; B Hakiki; M Giannini; L Pastò; L Razzolini
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

Review 3.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 4.  The neuropsychology of multiple sclerosis: contributions of neuroimaging research.

Authors:  H A Wishart; L Flashman; A J Saykin
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

5.  Memory dysfunction in multiple sclerosis corresponds to juxtacortical lesion load on fast fluid-attenuated inversion-recovery MR images.

Authors:  D M Moriarty; A J Blackshaw; P R Talbot; H L Griffiths; J S Snowden; V F Hillier; S Capener; R D Laitt; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

6.  Effects of acute relapses on neuropsychological status in multiple sclerosis patients.

Authors:  S A Morrow; S Jurgensen; F Forrestal; Frederick E Munchauer; R H B Benedict
Journal:  J Neurol       Date:  2011-03-08       Impact factor: 4.849

Review 7.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

8.  Working memory deficits in multiple sclerosis: a controlled study with auditory P600 correlates.

Authors:  C Sfagos; C C Papageorgiou; K K Kosma; E Kodopadelis; N K Uzunoglu; D Vassilopoulos; A D Rabavilas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 9.  Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management.

Authors:  Bridget Bagert; Patricia Camplair; Dennis Bourdette
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis.

Authors:  Francesco Mori; Hajime Kusayanagi; Fabio Buttari; Barbara Centini; Fabrizia Monteleone; Carolina Gabri Nicoletti; Giorgio Bernardi; Elisabetta Verdun Di Cantogno; Maria Grazia Marciani; Diego Centonze
Journal:  Funct Neurol       Date:  2012 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.